These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 181193)

  • 21. [Effect of bromocryptin on the alcohol consumption and catecholamine level in the brain of rats undergoing long-term alcoholization].
    Stanishevskaia AV; Kogan BM; Khristoliubova NA; Anokhina IP
    Farmakol Toksikol; 1985; 48(3):88-91. PubMed ID: 4040870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Biochemical studies in delirium tremens (author's transl)].
    Athen D; Beckmann H; Ackenheil M; Markianos E
    Arzneimittelforschung; 1978; 28(9):1527-8. PubMed ID: 582551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control of acute alcoholic withdrawal symptoms: a comparative study of haloperidol and chlordiazepoxide.
    Palestine ML; Alatorre E
    Curr Ther Res Clin Exp; 1976 Sep; 20(3):289-99. PubMed ID: 822987
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of clonidine withdrawal: possible mechanisms and suggestions for management.
    Hunyor SN; Hansson L; Harrison TS; Hoobler SW
    Br Med J; 1973 Apr; 2(5860):209-11. PubMed ID: 4700009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the changes in central catecholamine systems following short- and long-term lithium treatment and the consequences of lithium withdrawal.
    Ahluwalia P; Singhal RL
    Neuropsychobiology; 1984; 12(4):217-23. PubMed ID: 6152562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alcohol withdrawal syndrome: treatment and assessment of therapeutic efficacy.
    Jänne J; Malinen L
    J Int Med Res; 1979; 7(3):174-8. PubMed ID: 378727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sleep, psychological and clinical changes during alcohol withdrawal in NAD-treated alcoholics.
    Smith JW; Johnson LC; Burdick JA
    Q J Stud Alcohol; 1971 Dec; 32(4):982-94. PubMed ID: 4332864
    [No Abstract]   [Full Text] [Related]  

  • 28. Lithium carbonate in the management of cannabis withdrawal in humans: an open-label study.
    Winstock AR; Lea T; Copeland J
    J Psychopharmacol; 2009 Jan; 23(1):84-93. PubMed ID: 18515451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. IV. An evaluation of a role for cyclic adenosine monophosphate.
    Cubeddu L; Barnes E; Weiner N
    J Pharmacol Exp Ther; 1975 Apr; 193(1):105-27. PubMed ID: 166157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catecholamine responses in paraplegia.
    Frewin DB; Levitt M; Myers SJ; Co CC; Downey JA
    Paraplegia; 1973 Nov; 11(3):238-44. PubMed ID: 4764890
    [No Abstract]   [Full Text] [Related]  

  • 31. A double-blind trial of the efficacy of promazine in the treatment of alcohol withdrawal syndrome.
    Schwarz L; Schmidt H; Stern JA
    Dis Nerv Syst; 1968 Mar; 29(3):173-7. PubMed ID: 4877336
    [No Abstract]   [Full Text] [Related]  

  • 32. Partial inhibition by lithium of the epinephrine-stimulated rise in plasma cyclic GMP in humans.
    Belmaker RH; Kon M; Ebstein RP; Dasberg H
    Biol Psychiatry; 1980 Feb; 15(1):3-8. PubMed ID: 6244010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antianxiety drugs in alcohol withdrawal.
    Sellers EM
    Curr Psychiatr Ther; 1978; 18():157-63. PubMed ID: 38064
    [No Abstract]   [Full Text] [Related]  

  • 34. [Use of Atrium 300 in the withdrawal of alcoholic patients].
    Fontan M; Taine D
    Therapeutique; 1973; 49(7):463-6. PubMed ID: 4595358
    [No Abstract]   [Full Text] [Related]  

  • 35. Cyclic nucleotides in mental disorder.
    Belmaker RH; Zohar J; Ebstein RP
    Adv Cyclic Nucleotide Res; 1980; 12():187-98. PubMed ID: 6250353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of lithium and lithium withdrawal on potassium-evoked dopamine release and tyrosine hydroxylase expression in the rat.
    Ferrie L; Young AH; McQuade R
    Int J Neuropsychopharmacol; 2006 Dec; 9(6):729-35. PubMed ID: 16313702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stopping lithium prophylaxis.
    Merry J
    Br Med J; 1979 Mar; 1(6167):893. PubMed ID: 435868
    [No Abstract]   [Full Text] [Related]  

  • 38. Concentration of dopamine in plasma, activity of dopamine beta-hydroxylase in serum and urinary excretion of free catecholamines and vanillylmandelic acid in women chronically exposed to carbon disulphide.
    Stanosz S; Kuligowski D; Pieleszek A; Zuk E; Rzechuła D; Chlubek D
    Int J Occup Med Environ Health; 1994; 7(3):257-61. PubMed ID: 7842240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased sympathetic nervous system activity in alcoholic patients treated with disulfiram.
    Lake CR; Major LF; Ziegler MG; Kopin IJ
    Am J Psychiatry; 1977 Dec; 134(12):1411-4. PubMed ID: 920841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Individual difference in urinary excretion of salsolinol in alcoholic patients.
    Adachi J; Mizoi Y; Fukunaga T; Ueno Y; Imamichi H; Ninomiya I; Naito T
    Alcohol; 1986; 3(6):371-5. PubMed ID: 3814348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.